Status:
UNKNOWN
Interstitial Lung Disease Registry Construction
Lead Sponsor:
Seoul National University Hospital
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
20+ years
Brief Summary
The purpose of this study is investigating the clinical course, treatment course, and prognosis of patients with interstitial lung disease.
Detailed Description
Interstitial lung disease refers to pulmonary disease that occurs in the interstitium of the lung. It can be broadly classified into lung disease secondary to the cause of systemic disease or drug, a...
Eligibility Criteria
Inclusion
- Patients older than 20 years diagnosed with interstitial lung disease
- Diagnostic criteria for interstitial lung disease. If one of the following is met:
- clinical suspicion of idiopathic pulmonary fibrosis (IPF); Characteristic chest CT findings with honeycomb cysts and fibrosis and reasonable clinical signs
- suspected interstitial pneumonia, or confirmed by biopsy with no evidence of infection : IPF, Non-specific interstitial pneumonia(NSIP), Cryptogenic organizing pneumonia(COP), unclassified fibrosis
- interstitial lung disease suspects with underlying rheumatic disease
Exclusion
- No specific criteria
Key Trial Info
Start Date :
January 5 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03238989
Start Date
January 5 2014
End Date
December 31 2023
Last Update
August 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea